BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32070246)

  • 21. Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.
    van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman C; Mulder-de Tollenaer SM; Steiner K; Swarte RM; van Westering-Kroon E; Oei SG; Leemhuis AG; Andriessen P;
    Arch Dis Child Fetal Neonatal Ed; 2022 Sep; 107(5):467-474. PubMed ID: 35236745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-Response Effects of Early Vitamin D Supplementation on Neurodevelopmental and Respiratory Outcomes of Extremely Preterm Infants at 2 Years of Age: A Randomized Trial.
    Salas AA; Woodfin T; Phillips V; Peralta-Carcelen M; Carlo WA; Ambalavanan N
    Neonatology; 2018; 113(3):256-262. PubMed ID: 29393233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the outcome of infants born at <30 weeks' gestation--a randomized controlled trial of preventative care at home.
    Spittle AJ; Ferretti C; Anderson PJ; Orton J; Eeles A; Bates L; Boyd RN; Inder TE; Doyle LW
    BMC Pediatr; 2009 Dec; 9():73. PubMed ID: 19954550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome.
    Biswas S; Buffery J; Enoch H; Bland JM; Walters D; Markiewicz M
    Pediatrics; 2002 Feb; 109(2):222-7. PubMed ID: 11826199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Walsh V; Brown JVE; McGuire W
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD005253. PubMed ID: 30802939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation.
    Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
    J Pediatr; 1998 Jan; 132(1):64-9. PubMed ID: 9470002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
    Uchiyama A; Kushima R; Watanabe T; Kusuda S
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
    Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
    BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation.
    Ng SM; Turner MA; Gamble C; Didi M; Victor S; Weindling AM
    Trials; 2008 Mar; 9():17. PubMed ID: 18366798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants.
    Osborn DA
    Cochrane Database Syst Rev; 2001; (4):CD001070. PubMed ID: 11687092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium supplementation in pregnancy.
    Makrides M; Crosby DD; Bain E; Crowther CA
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000937. PubMed ID: 24696187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and Neurodevelopmental Outcomes of Preterms Resuscitated With Different Oxygen Fractions.
    Boronat N; Aguar M; Rook D; Iriondo M; Brugada M; Cernada M; Nuñez A; Izquierdo M; Cubells E; Martinez M; Parra A; van Goudoever H; Vento M
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial.
    Zhou SJ; Skeaff SA; Ryan P; Doyle LW; Anderson PJ; Kornman L; Mcphee AJ; Yelland LN; Makrides M
    Trials; 2015 Dec; 16():563. PubMed ID: 26654905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Dose Vitamin D Supplementation in Pregnancy and Neurodevelopment in Childhood: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Sass L; Vinding RK; Stokholm J; Bjarnadóttir E; Noergaard S; Thorsen J; Sunde RB; McGrath J; Bønnelykke K; Chawes B; Bisgaard H
    JAMA Netw Open; 2020 Dec; 3(12):e2026018. PubMed ID: 33289844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Ibrahim M; Sinn J; McGuire W
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005253. PubMed ID: 16625632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.
    Spencer L; Bubner T; Bain E; Middleton P
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011263. PubMed ID: 26387772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tract-Based Spatial Statistics in Preterm-Born Neonates Predicts Cognitive and Motor Outcomes at 18 Months.
    Duerden EG; Foong J; Chau V; Branson H; Poskitt KJ; Grunau RE; Synnes A; Zwicker JG; Miller SP
    AJNR Am J Neuroradiol; 2015 Aug; 36(8):1565-71. PubMed ID: 25929880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years.
    Pannek K; George JM; Boyd RN; Colditz PB; Rose SE; Fripp J
    Neuroimage; 2020 Nov; 221():117163. PubMed ID: 32663645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.